Technical Analysis for SNSE - Sensei Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 16.5 1.29% 0.21
SNSE closed up 1.29 percent on Friday, February 26, 2021, on 70 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical SNSE trend table...

Date Alert Name Type % Chg
Hot IPO Pullback Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
New 52 Week Closing Low Bearish 1.29%
Hot IPO Pullback Bullish Swing Setup 1.29%
New 52 Week Low Weakness 1.29%
Down 3 Days in a Row Weakness 1.29%
Down 4 Days in a Row Weakness 1.29%
Down 5 Days in a Row Weakness 1.29%
New 52 Week Closing Low Bearish 0.67%
Hot IPO Pullback Bullish Swing Setup 0.67%
Older End-of-Day Signals for SNSE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Trending on StockTwits 1 day ago
60 Minute Opening Range Breakdown 3 days ago
Down 3% 3 days ago
Down 2 % 3 days ago
Down 1% 3 days ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunotherapy Cancer Immunotherapy Virotherapy Tumor

Is SNSE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.5
52 Week Low 15.45
Average Volume 366,872
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 18.39
Average True Range 2.35
ADX 0.0
+DI 10.10
-DI 20.03
Chandelier Exit (Long, 3 ATRs ) 19.45
Chandelier Exit (Short, 3 ATRs ) 22.50
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -0.88
MACD Signal Line -0.40
MACD Histogram -0.4793
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 18.88
Resistance 3 (R3) 18.84 18.00 18.49
Resistance 2 (R2) 18.00 17.39 18.02 18.35
Resistance 1 (R1) 17.25 17.02 16.83 17.29 18.22
Pivot Point 16.41 16.41 16.20 16.43 16.41
Support 1 (S1) 15.66 15.80 15.24 15.71 14.78
Support 2 (S2) 14.82 15.43 14.84 14.65
Support 3 (S3) 14.07 14.82 14.51
Support 4 (S4) 14.12